103 related articles for article (PubMed ID: 26581140)
1. A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer.
Jung M; Shin SJ; Koom WS; Jung I; Keum KC; Hur H; Min BS; Baik SH; Kim NK; Kim H; Lim JS; Hong SP; Kim TI; Roh JK; Park YS; Ahn JB
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1015-22. PubMed ID: 26581140
[TBL] [Abstract][Full Text] [Related]
2. Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.
Landry JC; Feng Y; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Prabhu RS; Benson AB
Cancer; 2013 Apr; 119(8):1521-7. PubMed ID: 23288663
[TBL] [Abstract][Full Text] [Related]
3. Total Neoadjuvant Therapy (TNT) with Full Dose Concurrent Chemotherapy in Locally Advanced Rectal Adenocarcinoma Including Signet Ring and Mucinous Cancers.
John AO; Singh A; Bala D; Joel A; Georgy JT; Jesudasan MR; Mittal R; Ram TS; Reddy JR; Murthy A; Chandramohan A; Eapen A; Masih D; Ramnath N; Dobrosotskaya I; Yadav B; Chacko RT
J Gastrointest Cancer; 2024 Mar; 55(1):307-317. PubMed ID: 37479897
[TBL] [Abstract][Full Text] [Related]
4. Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial.
Kim MJ; Lee DW; Kang HC; Park JW; Ryoo SB; Han SW; Kim KS; Chie EK; Oh JH; Jeong WK; Kim BH; Nam EM; Jeong SY
BMC Cancer; 2023 Aug; 23(1):734. PubMed ID: 37553666
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.
Tan BR; Thomas F; Myerson RJ; Zehnbauer B; Trinkaus K; Malyapa RS; Mutch MG; Abbey EE; Alyasiry A; Fleshman JW; McLeod HL
J Clin Oncol; 2011 Mar; 29(7):875-83. PubMed ID: 21205745
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.
Michael M; Chander S; McKendrick J; MacKay JR; Steel M; Hicks R; Heriot A; Leong T; Cooray P; Jefford M; Zalcberg J; Bressel M; McClure B; Ngan SY
Br J Cancer; 2014 Nov; 111(10):1924-31. PubMed ID: 25211659
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer.
Imano N; Murakami Y; Kubo K; Kawahara D; Takeuchi Y; Nishibuchi I; Kimura T; Kochi M; Takakura Y; Shimizu W; Egi H; Uegami S; Ohge H; Takahashi S; Ohdan H; Nagata Y
J Radiat Res; 2021 Mar; 62(2):300-308. PubMed ID: 33341902
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Treatment of Locally Advanced Rectal Cancer.
Schrag D; Shi Q; Weiser MR; Gollub MJ; Saltz LB; Musher BL; Goldberg J; Al Baghdadi T; Goodman KA; McWilliams RR; Farma JM; George TJ; Kennecke HF; Shergill A; Montemurro M; Nelson GD; Colgrove B; Gordon V; Venook AP; O'Reilly EM; Meyerhardt JA; Dueck AC; Basch E; Chang GJ; Mamon HJ
N Engl J Med; 2023 Jul; 389(4):322-334. PubMed ID: 37272534
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Preoperative Transcatheter Rectal Arterial Chemoembolisation in Patients with Locally Advanced Rectal Cancer: Results from a Prospective, Phase II PCAR Trial.
Yang W; Qian C; Luo J; Chen C; Feng Y; Dai N; Li X; Xiao H; Yang Y; Li M; Li C; Wang D
Clin Oncol (R Coll Radiol); 2024 Apr; 36(4):233-242. PubMed ID: 38342657
[TBL] [Abstract][Full Text] [Related]
10. Compliance and Toxicity of Total Neoadjuvant Therapy for Rectal Cancer: A Secondary Analysis of the OPRA Trial.
Verheij FS; Omer DM; Lin ST; Yuval JB; Thompson HM; Kim JK; Valdivieso SC; Qin LX; Wu AJ; Saltz LB; Garcia-Aguilar J
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):115-123. PubMed ID: 37544412
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Bone Marrow Suppression During Postoperative Chemotherapy in Rectal Cancer Patients After Preoperative Chemoradiation Therapy.
Newman NB; Sidhu MK; Baby R; Moss RA; Nissenblatt MJ; Chen T; Lu SE; Jabbour SK
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1052-60. PubMed ID: 27026312
[TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer.
Thomas F; Motsinger-Reif AA; Hoskins JM; Dvorak A; Roy S; Alyasiri A; Myerson RJ; Fleshman JW; Tan BR; McLeod HL
Br J Cancer; 2011 Nov; 105(11):1654-62. PubMed ID: 22045187
[TBL] [Abstract][Full Text] [Related]
13. Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).
Basch E; Dueck AC; Mitchell SA; Mamon H; Weiser M; Saltz L; Gollub M; Rogak L; Ginos B; Mazza GL; Colgrove B; Chang G; Minasian L; Denicoff A; Thanarajasingam G; Musher B; George T; Venook A; Farma J; O'Reilly E; Meyerhardt JA; Shi Q; Schrag D
J Clin Oncol; 2023 Jul; 41(21):3724-3734. PubMed ID: 37270691
[TBL] [Abstract][Full Text] [Related]
14. [An update on total neoadjuvant treatment of adenocarcinoma of the rectum].
Medioni M; Cervantes B; Huguet F; Bachet JB; Parc Y; André T; Lefèvre JH; Cohen R
Bull Cancer; 2024 May; 111(5):483-495. PubMed ID: 38553289
[TBL] [Abstract][Full Text] [Related]
15. Impact of the new AJCC staging system and adjuvant treatment in rectal cancer.
Lee SA; Kwon HC; Park MA; Jung CK; Kim SH; Park KJ; Choi HJ; Lee HS; Roh MS; Kim JS; Kim HJ
Cancer Res Treat; 2004 Apr; 36(2):121-7. PubMed ID: 20396551
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer.
Baur M; Horvath M; Stättner S; Schratter-Sehn A; Horvath B; Sellner F; Hudec M; Klimpfinger M; Dittrich C; Karner J
Oncol Lett; 2010 Jan; 1(1):189-194. PubMed ID: 22966281
[TBL] [Abstract][Full Text] [Related]
17. Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer.
Boucher Y; Posada JM; Subudhi S; Kumar AS; Rosario SR; Gu L; Kumra H; Mino-Kenudson M; Talele NP; Duda DG; Fukumura D; Wo JY; Clark JW; Ryan DP; Fernandez-Del Castillo C; Hong TS; Pittet MJ; Jain RK
Clin Cancer Res; 2023 Apr; 29(8):1605-1619. PubMed ID: 36749873
[TBL] [Abstract][Full Text] [Related]
18. Which Treatment for Which Patient: Rectal Cancer Management After PROSPECT Trial.
Felder S; Frakes J; George M; Rosen A; Sahin IH
Oncology (Williston Park); 2024 May; 38(5):187-190. PubMed ID: 38776515
[TBL] [Abstract][Full Text] [Related]
19. A Phase II Study of S-1 for Previously Untreated Elderly Patients with Advanced Non-Small Cell Lung Cancer.
Kasai T; Nakamura Y; Fukuda M; Kitazaki T; Nagashima S; Takatani H; Nakano H; Nakatomi K; Ikeda T; Yamaguchi H; Tsukamoto K; Oka M; Kohno S
Chemotherapy; 2016; 61(2):93-8. PubMed ID: 26606381
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.
Okabe H; Hata H; Ueda S; Zaima M; Tokuka A; Yoshimura T; Ota S; Kinjo Y; Yoshimura K; Sakai Y;
J Surg Oncol; 2016 Jan; 113(1):36-41. PubMed ID: 26604064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
